HCCI's research on insulin prices was featured in a Bloomberg Law article. From the article: "The inventor who discovered insulin in the 1920s famously sold the patent to the University of Toronto for $1 in the hope that anyone who needed it could afford it.In the years since, the four most common types of insulin have seen their prices soar, with the average price per month rising to $...
HCCI, Duke, and Blue Cross and Blue Shield of North Carolina release interactive data on state health care spending to inform the public and policymakers. DURHAM, NC – Researchers at The Health Care Cost Institute, Duke-Margolis Center for Health Policy, Duke University School of Medicine Department of Population Health Sciences, and Blue Cross and Blue Shield of Nort...
In the start of 2019, Centers for Medicare and Medicaid Services finalized federal policies that required hospitals to publish the amount they charge for common services, documents commonly referred to as chargemasters. While similar policies have been in place at the state level since the early 2000s, this was the first federal mandate to require this type of transparency. These policies have bee...
HCCI's research on daily deaths during the coronavirus pandemic was featured in a Time article. From the article: "City health officials reported about 200 at-home deaths per day during the height of the pandemic, compared with a daily average of 35 between 2013 and 2017. Again, experts believe that excess is presumably caused either directly or indirectly by the pandemic. And nationally, a ...
Alzheimer's disease and related dementias (ADRD) represent a significant and growing cost to the United States health care system. While the prevalence and cost of ADRD related to Medicare Fee-for-Service beneficiaries is documented in the Center for Medicare and Medicaid Services' Chronic Conditions Warehouse, less is known about the prevalence and cost of ADRD among individuals covered by employ...
